mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.0006 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.17 |
0.0006 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0006 |
mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
0.15 |
0.0007 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.002 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |